Gilead teams up with WHO again to eliminate parasitic tropical disease
Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part…
21 May 2026
Eli Lilly maintains M&A streak with $202m Engage Bio buyout
Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics for up to $202m in cash, marking another addition to the company’s growing genetic medicines roster. At the centrepiece of…
21 May 2026
FUJIFILM opens new iPSC facility in Madison, US
FUJIFILM Cellular Dynamics has opened a new headquarters and induced pluripotent stem cell (iPSC) manufacturing facility in Madison, Wisconsin, US. The site is anticipated to expand the company’s production capacity…
21 May 2026
BMS and Anthropic collaborate for Claude implementation
Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations. The initiative will embed agentic capabilities throughout BMS’ research, clinical,…
20 May 2026
Investment giants join forces to form largest healthcare firm on the globe
Two key healthcare investors have merged to create the largest dedicated investment manager in their specialist sector, which will see the duo hold more than $21bn in combined assets. Through…
20 May 2026
Clinical Trials Day 2026: ‘Research Rising’ theme reflected in Q1 study growth
As 20 May marks Clinical Trials Day 2026, the ‘Research Rising’ theme has never seemed so apt, as trial initiations in Q1 2026 saw an uptick, with key R&D player…
20 May 2026
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict
Takeda has been ordered to pay $885m – potentially rising to $2.5bn – after a landmark court case verdict found the Japanese pharma company liable for a conspired arrangement to…